What is often forgotten is that Mesoblast Covid-19 ARDS RCT is funded by NIH, they have a strong voice.
So, the FDA cannot just do what they want e.g. as per Ryoncil non-approval
Both NIH and FDA are part of the PHEMCE
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment, page-351
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.003(0.21%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $2.025M | 1.729M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 43043 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 23151 | 5 |
View Market Depth
| Last trade - 12.33pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |